Curie.Bio
Curie.Bio is a new VC model created to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. We operate globally and we manage two funds: the Seed Fund and the Breakout Fund. The Seed Fund focuses on advancing therapies through preclinical milestones, such as achieving in vivo proof-of-concept or selecting a development candidate. The Breakout Fund focuses on advancing medicines through clinical trials to generate impactful human activity data.